Aliskiren Behandling med Aliskiren op til 300 mg resulterede i en generel incidens af bivirkninger, der svarede til placebo.
Aliskiren Treatment with Aliskiren up to 300 mg resulted in an overall incidence of adverse reactions similar to placebo.